LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO Read more about LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO China202280082940.2Filed on 2024-06-14
LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO Read more about LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO Canada3241884Filed on 2024-06-05
SYSTEM AND PROTOCOL FOR MONITORING PREGNANCY HEALTH Read more about SYSTEM AND PROTOCOL FOR MONITORING PREGNANCY HEALTH US Application 63/451,066Filed on 2023-03-09
Single Source-Detector Separation Approach to Calculate Tissue Oxygen Saturation Read more about Single Source-Detector Separation Approach to Calculate Tissue Oxygen Saturation US Application 63/434,827Filed on 2022-12-22
METHODS OF TREATING NEONATAL LIVER DISEASE Read more about METHODS OF TREATING NEONATAL LIVER DISEASE US Application 63/311,652Filed on 2022-02-18
NESTORONE® / TESTOSTERONE TRANSDERMAL GEL Read more about NESTORONE® / TESTOSTERONE TRANSDERMAL GEL US Application 63/339,563Filed on 2022-05-09
Systems And Methods To Predict Risk For Preterm Labor And/or Preterm Birth Read more about Systems And Methods To Predict Risk For Preterm Labor And/or Preterm Birth US Application 62/488,653Filed on 2017-04-21
Kits And Methods For Predictions And Treatment Of Preeclampsia Read more about Kits And Methods For Predictions And Treatment Of Preeclampsia US Application 62/251,589Filed on 2015-11-05
Kits And Methods To Distinguish False Labor And True Labor Read more about Kits And Methods To Distinguish False Labor And True Labor US Application 62/251,517Filed on 2015-11-05
Use of Carboxypeptidase E / Neurotrophic Factor-Alpha 1 to Treat Neurodegenerative Disease Read more about Use of Carboxypeptidase E / Neurotrophic Factor-Alpha 1 to Treat Neurodegenerative Disease US Application 63/273,312Filed on 2021-10-29